357 related articles for article (PubMed ID: 20649476)
1. Derivation of Huntington's disease-affected human embryonic stem cell lines.
Bradley CK; Scott HA; Chami O; Peura TT; Dumevska B; Schmidt U; Stojanov T
Stem Cells Dev; 2011 Mar; 20(3):495-502. PubMed ID: 20649476
[TBL] [Abstract][Full Text] [Related]
2. Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient.
Chae JI; Kim DW; Lee N; Jeon YJ; Jeon I; Kwon J; Kim J; Soh Y; Lee DS; Seo KS; Choi NJ; Park BC; Kang SH; Ryu J; Oh SH; Shin DA; Lee DR; Do JT; Park IH; Daley GQ; Song J
Biochem J; 2012 Sep; 446(3):359-71. PubMed ID: 22694310
[TBL] [Abstract][Full Text] [Related]
3. Lack of huntingtin promotes neural stem cells differentiation into glial cells while neurons expressing huntingtin with expanded polyglutamine tracts undergo cell death.
Conforti P; Camnasio S; Mutti C; Valenza M; Thompson M; Fossale E; Zeitlin S; MacDonald ME; Zuccato C; Cattaneo E
Neurobiol Dis; 2013 Feb; 50():160-70. PubMed ID: 23089356
[TBL] [Abstract][Full Text] [Related]
4. Proteomics of Huntington's disease-affected human embryonic stem cells reveals an evolving pathology involving mitochondrial dysfunction and metabolic disturbances.
McQuade LR; Balachandran A; Scott HA; Khaira S; Baker MS; Schmidt U
J Proteome Res; 2014 Dec; 13(12):5648-59. PubMed ID: 25316320
[TBL] [Abstract][Full Text] [Related]
5. Human embryonic stem cell models of Huntington disease.
Niclis J; Trounson AO; Dottori M; Ellisdon A; Bottomley SP; Verlinsky Y; Cram D
Reprod Biomed Online; 2009 Jul; 19(1):106-13. PubMed ID: 19573298
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal instability during neurogenesis in Huntington's disease.
Ruzo A; Croft GF; Metzger JJ; Galgoczi S; Gerber LJ; Pellegrini C; Wang H; Fenner M; Tse S; Marks A; Nchako C; Brivanlou AH
Development; 2018 Jan; 145(2):. PubMed ID: 29378824
[TBL] [Abstract][Full Text] [Related]
7. A novel human embryonic stem cell-derived Huntington's disease neuronal model exhibits mutant huntingtin (mHTT) aggregates and soluble mHTT-dependent neurodegeneration.
Lu B; Palacino J
FASEB J; 2013 May; 27(5):1820-9. PubMed ID: 23325320
[TBL] [Abstract][Full Text] [Related]
8. Expanded CAG repeats in the murine Huntington's disease gene increases neuronal differentiation of embryonic and neural stem cells.
Lorincz MT; Zawistowski VA
Mol Cell Neurosci; 2009 Jan; 40(1):1-13. PubMed ID: 18625318
[TBL] [Abstract][Full Text] [Related]
9. Induced pluripotent stem cell lines from Huntington's disease mice undergo neuronal differentiation while showing alterations in the lysosomal pathway.
Castiglioni V; Onorati M; Rochon C; Cattaneo E
Neurobiol Dis; 2012 Apr; 46(1):30-40. PubMed ID: 22227000
[TBL] [Abstract][Full Text] [Related]
10. Autopsy-proven Huntington's disease with 29 trinucleotide repeats.
Kenney C; Powell S; Jankovic J
Mov Disord; 2007 Jan; 22(1):127-30. PubMed ID: 17115386
[TBL] [Abstract][Full Text] [Related]
11. Animal models of Huntington's disease: implications in uncovering pathogenic mechanisms and developing therapies.
Wang LH; Qin ZH
Acta Pharmacol Sin; 2006 Oct; 27(10):1287-302. PubMed ID: 17007735
[TBL] [Abstract][Full Text] [Related]
12. Three Huntington's Disease Specific Mutation-Carrying Human Embryonic Stem Cell Lines Have Stable Number of CAG Repeats upon In Vitro Differentiation into Cardiomyocytes.
Jacquet L; Neueder A; Földes G; Karagiannis P; Hobbs C; Jolinon N; Mioulane M; Sakai T; Harding SE; Ilic D
PLoS One; 2015; 10(5):e0126860. PubMed ID: 25993131
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress causes DNA triplet expansion in Huntington's disease mouse embryonic stem cells.
Jonson I; Ougland R; Klungland A; Larsen E
Stem Cell Res; 2013 Nov; 11(3):1264-71. PubMed ID: 24041806
[TBL] [Abstract][Full Text] [Related]
14. Pathogenic cellular phenotypes are germline transmissible in a transgenic primate model of Huntington's disease.
Putkhao K; Kocerha J; Cho IK; Yang J; Parnpai R; Chan AW
Stem Cells Dev; 2013 Apr; 22(8):1198-205. PubMed ID: 23190281
[TBL] [Abstract][Full Text] [Related]
15. Reprogramming Huntington monkey skin cells into pluripotent stem cells.
Chan AW; Cheng PH; Neumann A; Yang JJ
Cell Reprogram; 2010 Oct; 12(5):509-17. PubMed ID: 20936902
[TBL] [Abstract][Full Text] [Related]
16. Inducing huntingtin inclusion formation in primary neuronal cell culture and in vivo by high-capacity adenoviral vectors expressing truncated and full-length huntingtin with polyglutamine expansion.
Huang B; Schiefer J; Sass C; Kosinski CM; Kochanek S
J Gene Med; 2008 Mar; 10(3):269-79. PubMed ID: 18067195
[TBL] [Abstract][Full Text] [Related]
17. Generation of human embryonic stem cell line chHES-458 from abnormal embryos with HTT gene mutation.
Xie P; Sun Y; Zhou X; Chen J; Du J; Sun Y; Lu G; Lin G; Ouyang Q
Stem Cell Res; 2016 Nov; 17(3):627-629. PubMed ID: 27934595
[TBL] [Abstract][Full Text] [Related]
18. Parent-of-origin differences of mutant HTT CAG repeat instability in Huntington's disease.
Aziz NA; van Belzen MJ; Coops ID; Belfroid RD; Roos RA
Eur J Med Genet; 2011; 54(4):e413-8. PubMed ID: 21540131
[TBL] [Abstract][Full Text] [Related]
19. Paradoxical delay in the onset of disease caused by super-long CAG repeat expansions in R6/2 mice.
Morton AJ; Glynn D; Leavens W; Zheng Z; Faull RL; Skepper JN; Wight JM
Neurobiol Dis; 2009 Mar; 33(3):331-41. PubMed ID: 19130884
[TBL] [Abstract][Full Text] [Related]
20. Increased Steady-State Mutant Huntingtin mRNA in Huntington's Disease Brain.
Liu W; Chaurette J; Pfister EL; Kennington LA; Chase KO; Bullock J; Vonsattel JP; Faull RL; Macdonald D; DiFiglia M; Zamore PD; Aronin N
J Huntingtons Dis; 2013; 2(4):491-500. PubMed ID: 25062733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
